Clinical trial
Efficacy and Hemodynamic Safety of Low-dose Propofol Plus High-dose Alfentanil in Rapid Sequence Induction: A Prospective Non-randomized Interventional Study
NCT07730918 is registered in ClinicalTrials.gov with Aoyang Hospital Affiliated to Jiangsu University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Hemodynamic Safety of Low-dose Propofol Plus High-dose Alfentanil in Rapid Sequence Induction: A Prospective Non-randomized Interventional Study
- Lead sponsor
- Aoyang Hospital Affiliated to Jiangsu University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2025
- Completion date
- June 20, 2026
- Enrollment
- 172 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic instability during anesthesia, induction anesthesia, intubation